In this study, we systematically investigated the tumor microenvironment (TME) of breast cancer, including the ER+, HER2+, and TNBC subtypes, by integrating multiple datasets that leverage information from large cohorts of patients and cell samples, along with clinical data. This evidence concerns the gene ESR1 and breast carcinoma.